title: Rituximab for child with chronic relapsing autoimmune hemolytic anemia.
authors.forename: Shahla
authors.initials: S
authors.lastname: Ansari
authors.forename: Maryam
authors.initials: M
authors.lastname: Tashvighi
authors.forename: Bahram
authors.initials: B
authors.lastname: Darbandi
authors.forename: Bahram D
authors.initials: BD
authors.lastname: Arbani
authors.forename: Adel Bagher
authors.initials: AB
authors.lastname: Salimi
authors.forename: Mohamadreza
authors.initials: M
authors.lastname: Golpaygani
mesh_terms: D000293:Adolescent; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy* / Q000473:pathology; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab